[1] Ilic M, Ilic I (2016). Epidemiology of pancreatic cancer. World J Gastroenterol, 22:9694-9705.
[2] Mcguire S (2016). World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. Advances in Nutrition, 7:418-419.
[3] Bray F, Ferlay J, Soerjomataram I, al e (2018). Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 68:394-424.
[4] Conroy T, Van Laethem J-L (2019). Combination or single-agent chemotherapy as adjuvant treatment for pancreatic cancer? The Lancet Oncology.
[5] Boeck S, Heinemann V Improving post-surgical management of resected pancreatic cancer. Lancet, 390:847-848.
[6] Are C, Chowdhury S, Ahmad H, Ravipati A, Song T, Shrikandhe S, et al. Predictive global trends in the incidence and mortality of pancreatic cancer based on geographic location, socio-economic status, and demographic shift. Journal of Surgical Oncology.
[7] Xu B, Liu J, Xiang X, Liu S, Zhong P, Xie F, et al. (2018). Expression of miRNA-143 in Pancreatic Cancer and Its Clinical Significance. Cancer Biother Radiopharm, 33:373-379.
[8] Li X, Deng SJ, Zhu S, Jin Y, Cui SP, Chen JY, et al. (2016). Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway. Oncotarget, 7:6000-6014.
[9] Qadir MI, Faheem A (2017). miRNA: A Diagnostic and Therapeutic Tool for Pancreatic Cancer. Crit Rev Eukaryot Gene Expr, 27:197-204.
[10] Bhan A, Soleimani M, Mandal SS (2017). Long Noncoding RNA and Cancer: A New Paradigm. Cancer Res, 77:3965-3981.
[11] Fu Z, Chen C, Zhou Q, Wang Y, Zhao Y, Zhao X, et al. LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. Cancer Letters:S0304383517305694.
[12] Cheng D, Fan J, Ma Y, Zhou Y, Qin K, Shi M, et al. LncRNA SNHG7 promotes pancreatic cancer proliferation through ID4 by sponging miR-342-3p. Cell & Bioscience, 9.
[13] Dong XY, Guo P, Boyd J, Sun X, Li Q, Zhou W, et al. (2009). Implication of snoRNA U50 in human breast cancer. J Genet Genomics, 36:447-454.
[14] Okugawa Y, Toiyama Y, Toden S, Mitoma H, Nagasaka T, Tanaka K, et al. (2017). Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer. Gut, 66:107-117.
[15] Popov A, Szabo A, Mandys V Small nucleolar RNA U91 is a new internal control for accurate microRNAs quantification in pancreatic cancer. Bmc Cancer, 15:774.
[16] Goldman M, Craft B, Zhu J, Haussler D (2019). The UCSC Xena system for cancer genomics data visualization and interpretation. Cancer Research, 77:326470.
[17] MD R, DJ M, GK S (2010). edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics, 26:139-140.
[18] Ritchie ME, Belinda P, Di W, Hu Y, Law CW, Wei S, et al. (2015). \n limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research:7.
[19] Ernst J, Bar-Joseph Z STEM: a tool for the analysis of short time series gene expression data. 7:191-190.
[20] Yoshihama M, Nakao A, Kenmochi N (2013). snOPY: a small nucleolar RNA orthological gene database. Bmc Research Notes, 6:1-5.
[21] Yu G, Wang L-G, Han Y, He Q-Y clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 16:284-287.
[22] Gong J, Li Y, Liu C-j, Xiang Y, Li C, Ye Y, et al. A Pan-cancer Analysis of the Expression and Clinical Relevance of Small Nucleolar RNAs in Human Cancer. Cell Reports, 21:1968-1981.
[23] Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS (2003). MicroRNA targets in Drosophila. Genome Biol, 5:R1.
[24] Timaner M, Shaked Y (2019). Elucidating the roles of ASPM isoforms reveals a novel prognostic marker for pancreatic cancer. The Journal of Pathology.
[25] Zeng H, Chen W, R Z (2018). Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries. Lancet Global Health, 6:e555-e567.
[26] Pan X, Chen L (2019). Analysis of Expression Pattern of snoRNAs in Different Cancer Types with Machine Learning Algorithms. 20.
[27] Choudhury NR, Heikel G, Trubitsyna M, Kubik P, Nowak JS, Webb S, et al. (2017). RNA-binding activity of TRIM25 is mediated by its PRY/SPRY domain and is required for ubiquitination. 15:105.
[28] Wang Z, Tong D, Han C, Zhao Z, Wang X, Jiang T, et al. (2019). Blockade of miR-3614 maturation by IGF2BP3 increases TRIM25 expression and promotes breast cancer cell proliferation. EBioMedicine, 41:357-369.
[29] Li YH, Zhong M, Zang HL, Tian XF (2018). The E3 ligase for metastasis associated 1 protein, TRIM25, is targeted by microRNA-873 in hepatocellular carcinoma. Exp Cell Res, 368:37-41.
[30] Davanian H, Balasiddaiah A, Heymann R, Sundstrom M, Redenstrom P, Silfverberg M, et al. (2017). Ameloblastoma RNA profiling uncovers a distinct non-coding RNA signature. Oncotarget, 8:4530-4542.
[31] Zhang Y, Zhang B (2008). TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5. Mol Cancer Res, 6:1861-1871.
[32] Yeager A (2013). Investigation of caveolae-mediated endocytosis in response to interferon.
[33] Ruan W, Wang P, Feng S, Xue Y, Li Y (2016). Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes cell proliferation and migration by upregulating angiomotin gene expression in human osteosarcoma cells. Tumour Biol, 37:4065-4073.
[34] Gong Z, Zhang S, Zeng Z, Wu H, Yang Q, Xiong F, et al. (2014). LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2. PLoS One, 9:e110674.
[35] Zhai W, Li X, Wu S, Zhang Y, Pang H, Chen W (2015). Microarray expression profile of lncRNAs and the upregulated ASLNC04080 lncRNA in human endometrial carcinoma. Int J Oncol, 46:2125-2137.
[36] Zhao M, Wang J, Xi X, Tan N, Zhang L (2018). SNHG12 Promotes Angiogenesis Following Ischemic Stroke via Regulating miR-150/VEGF Pathway. Neuroscience, 390:231-240.
[37] Wang O, Yang F, Liu Y, Lv L, Ma R, Chen C, et al. (2017). C-MYC-induced upregulation of lncRNA SNHG12 regulates cell proliferation, apoptosis and migration in triple-negative breast cancer. Am J Transl Res, 9:533-545.
[38] Wang JZ, Xu CL, Wu H, Shen SJ (2017). LncRNA SNHG12 promotes cell growth and inhibits cell apoptosis in colorectal cancer cells. Braz J Med Biol Res, 50:e6079.
[39] Zhu H, Guo J, Shen Y, Dong W, Gao H, Miao Y, et al. (2018). Functions and Mechanisms of Tumor Necrosis Factor-alpha and Noncoding RNAs in Bone-Invasive Pituitary Adenomas. Clin Cancer Res, 24:5757-5766.
[40] Eckstein N, Haas B Clinical pharmacology and regulatory consequences of GnRH analogues in prostate cancer. European Journal of Clinical Pharmacology, 70:791-798.
[41] Yang Z, Yan Z, Chen L. 2012. in silico identification of novel cancer-related genes by comparative genomics of naked mole rat and rat.
[42] Wang CH, Qiao C, Wang RC, Zhou WP (2016). KiSS1mediated suppression of the invasive ability of human pancreatic carcinoma cells is not dependent on the level of KiSS1 receptor GPR54. Mol Med Rep, 13:123-129.
[43] McNally LR, Welch DR, Beck BH, Stafford LJ, Long JW, Sellers JC, et al. (2010). KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model. Clin Exp Metastasis, 27:591-600.
[44] Rathod SS, Rani SB, Khan M, Muzumdar D, Shiras A Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways. Febs Open Bio, 4:485-495.
[45] Fang RH, Ji XB (2018). [Advances in the research of the relationship between miRNA-29c and cancer]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 32:312-317.